These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 12193567)

  • 21. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
    Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
    Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
    Miura Y; Matsui H
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene.
    Cordier-Bussat M; Bernard C; Levenez F; Klages N; Laser-Ritz B; Philippe J; Chayvialle JA; Cuber JC
    Diabetes; 1998 Jul; 47(7):1038-45. PubMed ID: 9648826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
    Wang Y; Egan JM; Raygada M; Nadiv O; Roth J; Montrose-Rafizadeh C
    Endocrinology; 1995 Nov; 136(11):4910-7. PubMed ID: 7588224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.
    Drucker DJ; Jin T; Asa SL; Young TA; Brubaker PL
    Mol Endocrinol; 1994 Dec; 8(12):1646-55. PubMed ID: 7535893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.
    Scrocchi LA; Marshall BA; Cook SM; Brubaker PL; Drucker DJ
    Diabetes; 1998 Apr; 47(4):632-9. PubMed ID: 9568697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
    Lawrence MC; Bhatt HS; Easom RA
    Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
    Holst JJ
    Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of proglucagon transcription by activated transcription factor (ATF) 3 and a novel isoform, ATF3b, through the cAMP-response element/ATF site of the proglucagon gene promoter.
    Wang J; Cao Y; Steiner DF
    J Biol Chem; 2003 Aug; 278(35):32899-904. PubMed ID: 12815047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).
    Holz GG; Leech CA; Heller RS; Castonguay M; Habener JF
    J Biol Chem; 1999 May; 274(20):14147-56. PubMed ID: 10318832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. POU domain transcription factor brain 4 confers pancreatic alpha-cell-specific expression of the proglucagon gene through interaction with a novel proximal promoter G1 element.
    Hussain MA; Lee J; Miller CP; Habener JF
    Mol Cell Biol; 1997 Dec; 17(12):7186-94. PubMed ID: 9372951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
    Skoglund G; Hussain MA; Holz GG
    Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
    Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
    Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.